Logo (Sod0p 0004 01)
Sodium Phosphates Injection, Solution
Product Images NDC 63323-881
8 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sodium Phosphates (NDC 63323-881). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Sod0p 0004 02)
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 5 mL Vial Label)
Sodium Phosphates Injection, USP label for intravenous use by Fresenius Kabi USA, LLC. It lists the concentration as 15 mM phosphorus and 20 mEq sodium per 5 mL. The label states the solution must be diluted, is preservative-free, in a 5 mL single-dose vial, and includes detailed contents and storage instructions. The label also displays a barcode and the lot/expiration area.*
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 5 mL Tray Label)
Label for Sodium Phosphates Injection, USP, an intravenous solution by Fresenius Kabi USA, LLC. It specifies concentrations of 15 mM phosphorus and 20 mEq sodium per 5 mL, with active ingredients including monobasic sodium phosphate monohydrate (276 mg/mL) and dibasic sodium phosphate anhydrous (142 mg/mL). The label advises dilution, single-dose 5 mL vial packaging, and storage instructions at 20° to 25°C.*
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 15 mL Vial Label)
Sodium Phosphates Injection, USP label for 15 mL single dose vial. Contains monobasic sodium phosphate monohydrate 276 mg/mL and dibasic sodium phosphate anhydrous 142 mg/mL. Indicates 45 mM P and 60 mEq Na+ per 15 mL. Preservative free, for intravenous use only, must be diluted. Manufactured by Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 15 mL Tray Label)
Label for Sodium Phosphates Injection, USP, showing strengths of 45 mM P per 15 mL and 60 mEq Na+ per 15 mL. The product is preservative free and intended for intravenous use, supplied in 25 single-dose 15 mL vials. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. The label includes dilution caution, storage instructions at 20° to 25°C, and notes on sterility and lack of bacteriostat.*
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 50 mL Vial Label)
Sodium Phosphates Injection, USP vial label showing active ingredients monobasic sodium phosphate monohydrate 276 mg/mL and dibasic sodium phosphate anhydrous 142 mg/mL. The label indicates 150 mM P and 200 mEq Na per 50 mL, cautions that the solution must be diluted for intravenous use, and notes preservative-free 50 mL single dose vial. Manufacturer is Fresenius Kabi USA, LLC.*
Package Label (PRINCIPAL DISPLAY – Sodium Phosphates Injection, USP 50 mL Tray Label)
Sodium Phosphates Injection, USP label from Fresenius Kabi USA, LLC. The label states concentrations of 150 mM P and 200 mEq Na per 50 mL vial, with instructions to dilute before intravenous use. It mentions preservative-free single dose vials of 25 x 50 mL. Storage conditions and usage cautions are also included, along with a barcode and company website.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
